Land: Irland
Sprache: Englisch
Quelle: HMA (Heads of Medicines Agencies)
moxidectin 5 mg, triclabendazole 200 mg
Pfizer
QP54AB52
Pour-on solution
Moxidectin, combinations
Cattle
2011-12-15
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cydectin TriclaMox 5 mg/ml + 200 mg/ml Pour-on Solution for cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active substances Moxidectin 5.0 mg Triclabendazole 200.0 mg Excipients Butylhydroxytoluene (E321) 5.0 mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Pour-on solution. A clear, amber liquid. _ _ 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In cattle: Treatment of mixed trematode (fluke) and nematode infections caused by moxidectin and triclabendazole sensitive strains of: Parasite Adult stage Inhibited stages NEMATODES L4 GASTRO-INTESTINAL NEMATODES: _Haemonchus placei_ ● ● _Ostertagia ostertagi_ ● ● ● _Trichostrongylus axei_ ● ● _Nematodirus helvetianus_ ● ● _Cooperia oncophora_ ● ● _Cooperia punctata_ ● _Oesophagostomum radiatum_ ● _Bunostomum phlebotomum_ ● RESPIRATORY TRACT NEMATODE:_ _ _Dictyocaulus viviparus_ ● TREMATODES LIVER FLUKE:_ _ 6 – 8 weeks immatures _Fasciola hepatica_ ● ● The product has a persistent effect in preventing re-infection by _Ostertagia ostertagi_ and by _Dictyocaulus viviparus_ for 5 weeks after a single dose. 4.3 CONTRAINDICATIONS Do not use in cases of known hypersensitivity to the active substance(s) or to any of the excipient(s). 4.4 SPECIAL WARNINGS FO Lesen Sie das vollständige Dokument